Thomas Gad - Net Worth and Insider Trading
Thomas Gad Net Worth
The estimated net worth of Thomas Gad is at least $7 Million dollars as of 2024-04-25. Thomas Gad is the CHIEF BUSINESS OFFICER of Y-mAbs Therapeutics Inc and owns about 483,732 shares of Y-mAbs Therapeutics Inc (YMAB) stock worth over $7 Million. Details can be seen in Thomas Gad's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Thomas Gad has not made any transactions after 2024-03-05 and currently still holds the listed stock(s).
Transaction Summary of Thomas Gad
Thomas Gad Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Thomas Gad owns 1 companies in total, including Y-mAbs Therapeutics Inc (YMAB) .
Click here to see the complete history of Thomas Gad’s form 4 insider trades.
Insider Ownership Summary of Thomas Gad
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
YMAB | Y-mAbs Therapeutics Inc | 2024-03-05 | director & President and Chairman |
Thomas Gad Latest Holdings Summary
Thomas Gad currently owns a total of 1 stock. Thomas Gad owns 483,732 shares of Y-mAbs Therapeutics Inc (YMAB) as of March 5, 2024, with a value of $7 Million.
Latest Holdings of Thomas Gad
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
YMAB | Y-mAbs Therapeutics Inc | 2024-03-05 | 483,732 | 15.00 | 7,255,980 |
Holding Weightings of Thomas Gad
Thomas Gad Form 4 Trading Tracker
According to the SEC Form 4 filings, Thomas Gad has made a total of 77 transactions in Y-mAbs Therapeutics Inc (YMAB) over the past 5 years, including 0 buys and 77 sells. The most-recent trade in Y-mAbs Therapeutics Inc is the sale of 3,900 shares on March 5, 2024, which brought Thomas Gad around $64,116.
Insider Trading History of Thomas Gad
- 1
Thomas Gad Trading Performance
Thomas Gad Ownership Network
Ownership Network List of Thomas Gad
Ownership Network Relation of Thomas Gad
Thomas Gad Owned Company Details
What does Y-mAbs Therapeutics Inc do?
Who are the key executives at Y-mAbs Therapeutics Inc?
Thomas Gad is the director & President and Chairman of Y-mAbs Therapeutics Inc. Other key executives at Y-mAbs Therapeutics Inc include SVP and CMO Vignesh Rajah , Senior Vice President & CCO Susan Laura Smith , and director & 10 percent owner Johan Wedell-wedellsborg .
Y-mAbs Therapeutics Inc (YMAB) Insider Trades Summary
Over the past 18 months, Thomas Gad made 3 insider transaction in Y-mAbs Therapeutics Inc (YMAB) with a net sale of 303,900. Other recent insider transactions involving Y-mAbs Therapeutics Inc (YMAB) include a net purchase of 380,768 shares made by Biotech Aps Wg , a net purchase of 380,768 shares made by Johan Wedell-wedellsborg , and a net sale of 516 shares made by Vignesh Rajah .
In summary, during the past 3 months, insiders sold 7,293 shares of Y-mAbs Therapeutics Inc (YMAB) in total and bought 0 shares, with a net sale of 7,293 shares. During the past 18 months, 307,293 shares of Y-mAbs Therapeutics Inc (YMAB) were sold and 762,731 shares were bought by its insiders, resulting in a net purchase of 455,438 shares.
Y-mAbs Therapeutics Inc (YMAB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Y-mAbs Therapeutics Inc Insider Transactions
Thomas Gad Mailing Address
Above is the net worth, insider trading, and ownership report for Thomas Gad. You might contact Thomas Gad via mailing address: C/o Y-mabs Therapeutics, Inc., 230 Park Avenue, 33rd Floor, New York Ny 10169.